Les prix des medicaments sur un marche global politiques et enjeux.

The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
منشور في: (2003)

Profits before people? ethical standards and the marketing of prescription drugs /
حسب: Weber, Leonard J., 1942-
منشور في: (2006)

CAPA for the FDA-regulated industry /
حسب: Rodríguez Pérez, José, 1961-
منشور في: (2010)

The $800 million pill the truth behind the cost of new drugs /
حسب: Goozner, Merrill, 1950-
منشور في: (2004)

Pharmaceutical blending and mixing /
منشور في: (2015)

The agile approach to adaptive research optimizing efficiency in clinical development /
حسب: Rosenberg, Michael J.
منشور في: (2010)

Therapeutic targets modulation, inhibition, and activation /
منشور في: (2012)

Manufacturing of pharmaceutical proteins : from technology to economy /
حسب: Behme, Stefan
منشور في: (2015)

Towards drugs of the future key issues in lead finding and lead optimization /
منشور في: (2008)

The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
منشور في: (2006)

Innovation in the biopharmaceutical industry
منشور في: (2007)

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
حسب: Cook, Arthur G.
منشور في: (2006)

Negotiating health : intellectual property and access to medicines /
منشور في: (2006)

Extractables & Leachables for Pharmaceutical Products 2011 : [conference proceedings] : Dublin, Ireland, 27-28 September 2011 /
منشور في: (2011)

Extractables & Leachables : [E & L 2012 conference proceedings] : delivering pharmaceuticals safely : 12-13 December 2012, Vienna, Austria /
منشور في: (2012)

E & L USA : Extractables & Leachables : [conference proceedings] : delivering pharmaceuticals safely : 7-9 May 2013, Providence, RI, USA /
منشور في: (2013)

Medicines as a service a new commercial model for big pharma in the postblockbuster world /
حسب: Mattke, Soeren
منشور في: (2012)

Pharmaceutical industry innovation and developments /
منشور في: (2011)

Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
منشور في: (2004)

Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
منشور في: (2007)

Crystallization of organic compounds an industrial perspective /
حسب: Tung, Hsien-Hsin, 1955-
منشور في: (2009)

Continuous processing in pharmaceutical manufacturing /
منشور في: (2015)

Drugs : from discovery to approval /
حسب: Ng, Rick
منشور في: (2015)

Outsourcing clinical development strategies for working with CROs and other partners /
منشور في: (2006)

The Perception of Kenyan Doctors on the Various Differentiation Strategies Used by Multinationals to Build Brand Equity within the Pharmaceutical Industry
حسب: Okoth, Anthony S.
منشور في: (2025)

Glocal pharma : international brands and the imagination of local masculinity /
حسب: Johnson, Ericka
منشور في: (2016)

Drug repositioning bringing new life to shelved assets and existing drugs /
منشور في: (2012)

ADME-enabling technologies for drug design and development
منشور في: (2012)

Cracking the code understand and profit from the biostech revolution that will transform our lives and generate fortunes /
حسب: Mellon, Jim
منشور في: (2012)

The risks of prescription drugs
منشور في: (2010)

Pharmaceutical reform a guide to improving performance and equity /
حسب: Roberts, Marc J.
منشور في: (2011)

Measuring transparency to improve good governance in the public pharmaceutical sector.
منشور في: (2009)

Measuring transparency to improve good governance in the public pharmaceutical sector.
منشور في: (2009)

Coherence for health innovation for new medicines for infectious diseases.
منشور في: (2009)

Threats and opportunities for European pharmaceutical wholesalers in a changing healthcare environment
حسب: Cmolik, Andreas
منشور في: (2012)

Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
حسب: Willig, Sidney H., 1919-
منشور في: (2000)